跳至主要内容
临床试验/NCT00576550
NCT00576550已完成4 期

A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema

ACO Hud Nordic AB3 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
53
试验地点
3
主要终点
Time to relapse of hand eczema

研究概览

简要总结

The purpose of this study is to investigate whether a moisturizing cream can prevent hand eczema.Patients with previous hand eczema will be studied. In the second part of the study, it will be explored if a treatment regimen of a topical corticosteroid once daily is not inferior to treatment twice daily.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically proven history of hand eczema
  • At inclusion controlled state of hand eczema (≤3 on Hand Eczema Extent Score, HEES)
  • Daily use of moisturising treatment
  • Either gender
  • Age 18 or above
  • Written Informed Consent

排除标准

  • Possible allergy to ingredients in the study medications
  • At study start active psoriatic lesions or active atopic eczema lesions on the hands. Active bacterial, fungal or viral infection of the hands
  • Patients who are pregnant or breast-feeding, or who plan to become pregnant during the course of the study
  • Use of any concomitant medication that may interfere with the study related activities or assessment of efficacy
  • Any patient related factor suggesting potential poor compliance with study procedures (e.g. psychiatric disorders, history of alcohol or substance abuse)
  • Any serious medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results
  • Inclusion in a study of an investigational drug within 60 days prior to start of treatment

研究组 & 干预措施

1:1

Experimental

Part 1 of the study (maintenance part)

干预措施: Urea (Drug)

2:1

Experimental

Part 2 of the study (eczema part)

干预措施: betamethasone valerate (Drug)

2:2

Active Comparator

Part 2 of the study (eczema part)

干预措施: betamethasone valerate (Drug)

结局指标

主要结局

Time to relapse of hand eczema

时间窗: Up to 6 months

次要结局

  • The number of patients showing clearance of hand eczema after betamethasone treatment once versus twice daily(2 weeks)

研究者

申办方类型
Industry

研究点 (3)

Loading locations...

相似试验